Leigh Ann Anderson's articles Pharmaceuticals and Drug Development Monthly News Roundup – June 2024 Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on June 30, 2024. FDA Grants Expanded Approval to Skyrizi for Ulcerative Colitis On June 18th, the U.S. Food and Drug Administration (FDA) approved AbbVie’s Skyrizi (risankizumab-rzaa) for adults with moderately to severely active ulcerative colitis (UC). Skyrizi is also approved to treat adults with plaque […] Written by Leigh Ann Anderson July 1, 2024July 1, 2024 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development Monthly News Roundup – June 2024 Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on June 30, 2024. FDA Grants Expanded Approval to Skyrizi for Ulcerative Colitis On June 18th, the U.S. Food and Drug Administration (FDA) approved AbbVie’s Skyrizi (risankizumab-rzaa) for adults with moderately to severely active ulcerative colitis (UC). Skyrizi is also approved to treat adults with plaque […] Written by Leigh Ann Anderson July 1, 2024July 1, 2024 Saving Bookmark this article Bookmarked
